Jude Children's Research Hospital confirmed activation of the SHH pathway and, by DNA methylation profiling identified a “methylation class medulloblastoma, group SHH, Subgroup 4” with high confidence (calibrated score = 0.99). This evidence concerns the gene SHH and medulloblastoma.